Continuous bioprocessing: A ‘life changing’ method, says NIBRT

By Flora Southey contact

- Last updated on GMT

NIBRT is embracing continuous bioprocessing says training director John Milne, who told us the method helps improve plant flexibility and could reduce manufacturing costs.

On a site visit last month at Ireland’s National Institute for Bioprocessing Research and Technology (NIBRT) in Dublin, Milne told Biopharma-Reporter the continuous method – as opposed to batch – is attracting increased interest in the biologics space.

“In the small molecule industry for example, people have been applying these strategies.

“Biologics has taken a longer time to be convinced,” ​said Milne, but added he has observed a lot of activity in continuous manufacturing, and will “definitely see more.”

“It is going to change our lives in a very positive way going forward.”

Speaking to delegates at the Biopharma Ambition Conference – also in Dublin – CEO Dominic Carolan said the bioprocessing method has not been taken onboard by all firms.

“Some companies are certainly looking at it closely, some companies have decided perhaps it’s not for them at this point.

“The technologies need to be developed, because this has huge potential of course for reducing cost in the future,” ​he added.

Continuous bioprocessing training is gaining traction, as demonstrated by Pall Life Sciences announcement​ last year to equip a Swiss training facility in order to theoretical and practical training in the continuous method to biomanufacturers.

Related news

Show more

Related products

show more

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 10-Feb-2021 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 10-Feb-2021 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Rapid Biosafety Testing Enables the Future of Manufacturing

Rapid Biosafety Testing Enables the Future of Manufacturing

Viral Safety for mAb: Prevent, Detect, Remove | 23-Nov-2020 | Technical / White Paper

This white paper explores the factors driving the evolution toward faster biosafety testing and describes rapid approaches for adventitious agent testing...

Related suppliers

Follow us

Products

View more

Webinars